Acetyl-L-Carnitine
Acetylated form of L-carnitine. Crosses the blood-brain barrier (unlike L-carnitine). Donates acetyl group for acetylcholine synthesis. Supports mitochondrial fatty acid oxidation. Antioxidant at neuronal membrane level.
Stronger evidence base than many nootropics. Meta-analyses show benefit in diabetic neuropathy (nerve conduction), mild cognitive impairment (MCI) progression, and fatigue in MS/cancer patients. Cognitive enhancement in healthy young adults is less well-supported — effect sizes are small and may reflect cholinergic boost in people with suboptimal choline intake. Stacks well with Alpha-GPC for additive cholinergic effect.
Fishy body odor at high doses (trimethylamine production by gut bacteria) — common with L-carnitine, less so ALCAR. May increase TMAO (trimethylamine N-oxide) — cardiovascular risk signal is debated. Stimulant-sensitive individuals: ALCAR can be mildly activating (best taken AM).
External links to PubMed searches, ClinicalTrials.gov, and FDA materials. We do not host papers — we point at canonical sources.
Dietary supplement (DSHEA). L-Carnitine is FDA-approved for primary carnitine deficiency — ALCAR is not a separate drug approval.
Distilled themes from named communities — Reddit threads, forums, creator commentary. Not direct quotes; not clinical evidence. Useful for calibrating expectations against what real self-experimenters report.
Commonly stacked with Alpha-GPC (500 mg ALCAR + 300 mg Alpha-GPC). Reports of increased verbal fluency and morning alertness. A minority report headaches — choline sensitivity is the proposed cause.